1. Home
  2. BBW vs ARVN Comparison

BBW vs ARVN Comparison

Compare BBW & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$55.91

Market Cap

696.0M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$13.48

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
ARVN
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
696.0M
781.0M
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
BBW
ARVN
Price
$55.91
$13.48
Analyst Decision
Strong Buy
Buy
Analyst Count
7
23
Target Price
$67.71
$18.14
AVG Volume (30 Days)
299.6K
754.3K
Earning Date
03-12-2026
02-11-2026
Dividend Yield
1.59%
N/A
EPS Growth
15.02
N/A
EPS
4.36
N/A
Revenue
$525,767,000.00
$312,300,000.00
Revenue This Year
$8.05
$10.55
Revenue Next Year
$4.31
N/A
P/E Ratio
$12.72
N/A
Revenue Growth
6.17
93.86
52 Week Low
$32.55
$5.90
52 Week High
$75.85
$20.38

Technical Indicators

Market Signals
Indicator
BBW
ARVN
Relative Strength Index (RSI) 34.14 57.38
Support Level $54.08 $12.88
Resistance Level $61.82 $14.14
Average True Range (ATR) 2.46 0.70
MACD -1.34 0.02
Stochastic Oscillator 7.00 67.89

Price Performance

Historical Comparison
BBW
ARVN

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: